American Century Companies Inc. Has $19.08 Million Position in DENTSPLY SIRONA Inc. $XRAY

American Century Companies Inc. lifted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 19.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 1,503,145 shares of the medical instruments supplier’s stock after purchasing an additional 248,457 shares during the period. American Century Companies Inc. owned 0.75% of DENTSPLY SIRONA worth $19,075,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Arizona State Retirement System lifted its position in DENTSPLY SIRONA by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 58,952 shares of the medical instruments supplier’s stock worth $748,000 after buying an additional 807 shares in the last quarter. True Wealth Design LLC increased its position in DENTSPLY SIRONA by 49.7% in the 3rd quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock valued at $45,000 after acquiring an additional 1,181 shares in the last quarter. Sivia Capital Partners LLC increased its position in DENTSPLY SIRONA by 5.3% in the 3rd quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock valued at $327,000 after acquiring an additional 1,293 shares in the last quarter. Empowered Funds LLC raised its stake in shares of DENTSPLY SIRONA by 8.8% in the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after acquiring an additional 1,320 shares during the last quarter. Finally, Parkside Financial Bank & Trust lifted its position in shares of DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,477 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA News Roundup

Here are the key news stories impacting DENTSPLY SIRONA this week:

• Positive Sentiment: FDA clearance for a dental‑dedicated MRI (ddMRI) with Siemens Healthineers: this first‑of‑its‑kind imaging system expands XRAY’s advanced‑imaging addressable market and could drive higher‑margin equipment sales and recurring service revenue over time. First-ever Dental Dedicated MRI Validated…
• Positive Sentiment: Insider buying from directors (James Forbes and Gregory Lucier): recent purchases (~$12.45–$12.48/share) signal management/board confidence in the stock at current levels and can support sentiment if the buys continue. DENTSPLY SIRONA (NASDAQ:XRAY) Director James Forbes Buys 5,000 Shares
• Neutral Sentiment: Analysts are reworking valuation and risk assumptions: coverage shifts and updated models (discussed in a Yahoo Finance piece) are causing targets and ratings to be revisited — this fuels near‑term volatility but could clarify consensus levels over weeks. How The Dentsply Sirona (XRAY) Story Is Shifting…
• Neutral Sentiment: Presentation transcript from the Leerink Global Healthcare Conference: useful for incremental detail on strategy, margin actions and product cadence — may influence analyst revisions but no single headline takeaway. DENTSPLY SIRONA Presents at Leerink…
• Neutral Sentiment: Short‑interest reports show data anomalies (reported as 0 shares / 0 days to cover) — current disclosures appear unreliable, so there is no clear short‑squeeze or elevated short‑pressure signal from these entries. (Data point: average volume references included in filings.)
• Negative Sentiment: Recent quarterly results/earnings mix: revenue beat but an EPS miss and a negative net margin keep focus on profitability and leverage (market cap and leverage metrics remain notable). Analysts’ target adjustments are mixed (some cuts, some raises), leaving consensus at a “Hold” with average target ~$14.4 — downside remains if execution or margin recovery slows. DENTSPLY SIRONA (XRAY) MarketBeat summary

Analyst Upgrades and Downgrades

Several analysts have recently commented on XRAY shares. Barrington Research increased their price target on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a research note on Monday, March 2nd. Zacks Research upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Monday, March 2nd. Robert W. Baird increased their price objective on DENTSPLY SIRONA from $12.00 to $14.00 and gave the company a “neutral” rating in a research report on Friday, February 27th. Bank of America raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and lifted their target price for the company from $13.00 to $17.00 in a research note on Thursday, February 19th. Finally, UBS Group dropped their target price on DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating for the company in a research report on Tuesday, February 3rd. Three equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $14.42.

DENTSPLY SIRONA Stock Down 0.9%

NASDAQ:XRAY opened at $12.68 on Wednesday. DENTSPLY SIRONA Inc. has a 1 year low of $9.85 and a 1 year high of $17.18. The stock has a 50-day moving average price of $12.69 and a two-hundred day moving average price of $12.43. The stock has a market cap of $2.53 billion, a price-to-earnings ratio of -4.23, a PEG ratio of 1.50 and a beta of 0.97. The company has a current ratio of 1.51, a quick ratio of 1.03 and a debt-to-equity ratio of 1.50.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, February 26th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.01). DENTSPLY SIRONA had a negative net margin of 16.25% and a positive return on equity of 18.85%. The business had revenue of $961.00 million for the quarter, compared to the consensus estimate of $926.40 million. During the same quarter last year, the firm earned $0.26 EPS. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,000 shares of the business’s stock in a transaction on Monday, March 9th. The shares were purchased at an average price of $12.45 per share, with a total value of $186,750.00. Following the completion of the purchase, the director owned 65,000 shares in the company, valued at $809,250. This represents a 30.00% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director James D. Forbes purchased 5,000 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 9th. The stock was bought at an average price of $12.48 per share, with a total value of $62,400.00. Following the acquisition, the director directly owned 10,000 shares of the company’s stock, valued at approximately $124,800. This trade represents a 100.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 70,000 shares of company stock worth $956,437 over the last 90 days. Corporate insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.